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HPV-Related Cancers

Abstract

Human Papillomavirus (HPV) is associated with more than
150 viruses.1 HPV is an infection of the basal epithelium and
transmission can occur either by direct contact or during
childbirth. More than 50% of sexually active people will be
infected with some form of HPV during their lifetime.2 Two
categories of sexually transmitted HPV include low-risk
HPVs, which are not cancer causing, and high-risk, or
oncogenic HPVs, which can lead to a cancer diagnosis.
Malignancies found to be associated with HPV infection
include cervical, vaginal, vulvar, penile and anal cancers as
well as cancers of the oropharynx. Treatment of HPV-related
cancers often includes surgery, chemotherapy and radiation
therapy. Health education and prevention is necessary to
reduce cancers related to HPV infections. Education on
abstinence and vaccinations are two methods proven to be
effective. The role of the health care provider is to educate
adolescents regarding the risk of sexually transmitted
disease and ways to protect themselves from HPV-related
cancers such as the cases reviewed in this exhibit.
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Case Study #1
A 59 year old female presented with a sore throat & sinus
issues for almost one year along with a right side neck mass.
Histology revealed HPV-16 related squamous cell carcinoma
of the tonsil measuring 5.8 cm. The tumor was staged as
T4a, N1, M0.

The pathogenesis of HPV involves viral particles which
enter the epithelial cells at areas of micro trauma, actively
targeting proliferating basal cells. As the infected cells
migrate away from the basal layer, viral DNA is packaged
into virions (infectious virus). When the epithelium is shed,
viral particles are released and are able to infect other cells
(Figure 1).2

Figure 1. Pathogenesis of

Both HPV vaccines currently available have proven efficacy
for prevention of HPV vaccine type-related persistent infection
and adenocarcinoma in-situ.3 Vaccination does not immunize
against, or help clear prior viral exposure.4
The efficacy drops precipitously in people previously exposed
to HPV. The only way to completely prevent getting HPV is
abstinence.

Side effects included: Skin erythema, severe mucositis and
constant xerostomia.
Prognosis – HPV related H & N Cancers
HPV + 62% 5 year survival rate
HPV – 26% 5 year survival rate

Case Study #2
A 72 year old female presented with a 3- 4 month history
of weight loss of 30 lbs., diarrhea and pain while sitting.
A CT of the pelvis revealed a large anorectal mass with
extension into the lower pelvis measuring 14 x 10 x 8 cm.
The histology report noted moderately differentiated
squamous cell carcinoma & the tumor was staged as
Stage cT4 cN0 cM0.

Due to the large treatment field, as noted in Image 2,
doses to the bowel and bladder were documented. Side
effects included diarrhea, abdominal cramps and skin
changes.
Prognosis - 65% 5 year survival rate (all stages)

Table 1. Vaccination comparison 5

Conclusion

Each year, there are an estimated 26,000 HPV-attributable
cancers in the United States. The CDC estimates that $8
billion are spent yearly on direct medical costs for preventing
and treating HPV-associated disease.6 Radiation therapy and
chemotherapy contribute to this overall cost. Education at the
adolescent/parental level is important to produce a decline in
HPV-related malignancies.
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Radiation therapy to a total dose of 5580 cGy was
prescribed at 180 cGy/fraction. The patient also received
5FU and mytomycin C.

HPV2

Vaccination was approved for females between the ages of 9
and 26 by the Food and Drug Administration in 2006 and for
males in 2009 (Table 1).

Radiation therapy to a dose of 6000cGy at 200cGy /fraction
over 30 fractions was prescribed (Image 1). The patient
received two cycles of concurrent chemotherapy.

Image 1. Treatment plan for tonsilar HPV-related cancer.
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Image 2. 3D reconstruction of anal HPV-related cancer.
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